Plain-English translation of NCT06669182 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Alzheimer Disease research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a procedure called transcranial magnetic stimulation (TMS) — a non-invasive treatment that uses magnetic pulses to stimulate a specific part of the brain called the cerebellum. Researchers believe this treatment might help improve memory and thinking abilities in people with Alzheimer's disease. The goal is to see if this treatment is safe and whether it can help slow or improve cognitive decline.
Alzheimer's disease damages memory and thinking, and current treatments have limited benefits. Recent research suggests that the cerebellum—a part of the brain that resists early damage from Alzheimer's—might be able to compensate for memory loss if it's stimulated properly. This trial tests whether magnetic brain stimulation can unlock that potential.
You likely qualify if…
You likely don't qualify if…
You will receive magnetic brain stimulation sessions targeting a specific brain region. For the first 4 weeks, you will come in daily for treatment, then once a week for 8 additional weeks. Some participants will receive the real treatment while others receive a sham (placebo) treatment—neither you nor the researchers will know which group you're in. Throughout the trial, you'll have brain scans and thinking tests to measure any changes in your memory and cognition.
AI-generated summary from trial data · Jun 13, 2026 · Not medical advice
China